Decoy Therapeutics Inc. (DCOY): Total Liabilities
$5.17M
As of 2025-12-31
$4.68M
As of 2026-06-30
+6.6%
3-year compound annual growth
+13.3%
5-year compound annual growth
+6.0%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.17M | +241.9% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $1.51M | +16.3% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $1.30M | -69.5% | 2025-03-21, Balance as of period end |
| 2022-12-31 | $4.27M | +102.1% | 2024-03-22, Balance as of period end |
| 2021-12-31 | $2.11M | -23.9% | 2023-03-27, Balance as of period end |
| 2020-12-31 | $2.77M | -16.3% | 2022-03-25, Balance as of period end |
| 2019-12-31 | $3.31M | -58.0% | 2021-03-18, Balance as of period end |
| 2018-12-31 | $7.88M | +33.9% | 2020-03-23, Balance as of period end |
| 2017-12-31 | $5.89M | +51.0% | 2019-03-06, Balance as of period end |
| 2016-12-31 | $3.90M | +35.5% | 2018-03-07, Balance as of period end |
| 2015-12-31 | $2.88M | +157.2% | 2017-03-08, Balance as of period end |
| 2014-12-31 | $1.12M | n/a | 2016-03-08, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | 2025-12-31 | $5.17M | +241.9% |
| Lantern Pharma Inc. (LTRN) | 2025-12-31 | $4.50M | +2.7% |
| Mira Pharmaceuticals, Inc. (MIRA) | 2025-12-31 | $702.1K | -2.9% |
| MetaVia Inc. (MTVA) | 2025-12-31 | $5.79M | -30.5% |
| NewcelX Ltd. (NCEL) | 2025-12-31 | $4.20M | -52.9% |
| Traws Pharma, Inc. (TRAW) | 2025-12-31 | $11.25M | -80.1% |
| Curanex Pharmaceuticals Inc (CURX) | 2025-12-31 | $361.0K | n/m |
| Revelation Biosciences, Inc. (REVB) | 2025-12-31 | $2.72M | +42.2% |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | 2025-12-31 | $8.22M | +357.5% |
Compare DCOY, LTRN, MIRA, MTVA side by side · Screen every company in Pharmaceutical Preparations ↗